Applied DNA Sciences, Inc. (BNBX) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Applied DNA Sciences, Inc. stock (BNBX) is currently trading at $0.73. Applied DNA Sciences, Inc. PS ratio (Price-to-Sales) is 2.41. WallStSmart rates BNBX as Sell.
- BNBX PE ratio analysis and historical PE chart
- BNBX PS ratio (Price-to-Sales) history and trend
- BNBX intrinsic value — DCF, Graham Number, EPV models
- BNBX stock price prediction 2025 2026 2027 2028 2029 2030
- BNBX fair value vs current price
- BNBX insider transactions and insider buying
- Is BNBX undervalued or overvalued?
- Applied DNA Sciences, Inc. financial analysis — revenue, earnings, cash flow
- BNBX Piotroski F-Score and Altman Z-Score
- BNBX analyst price target and Smart Rating
Applied DNA Sciences, Inc.
📊 No data available
Try selecting a different time range
BNBX Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Applied DNA Sciences, Inc. (BNBX)
BNBX trades at a significant discount to its Graham intrinsic value of $1920.25, offering a 100% margin of safety — a level value investors typically seek before buying.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Applied DNA Sciences, Inc. (BNBX) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in peg ratio, price/book. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
Applied DNA Sciences, Inc. (BNBX) Key Strengths (2)
Trading below book value, meaning the market prices it less than net assets
Good growth relative to its price
Supporting Valuation Data
Applied DNA Sciences, Inc. (BNBX) Areas to Watch (6)
Company is destroying shareholder value
Losing money on operations
Revenue declining -35.00%, a shrinking business
Very low institutional interest at 2.00%
Micro-cap company with very limited liquidity and high volatility
Revenue is fairly priced at 2.41x sales
Supporting Valuation Data
Applied DNA Sciences, Inc. (BNBX) Detailed Analysis Report
Overall Assessment
This company scores 32/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 2 register as strengths (avg 9.0/10) while 6 fall into concern territory (avg 1.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Book, PEG Ratio. Valuation metrics including PEG Ratio (1.27), Price/Book (0.23) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Some valuation metrics including Price/Sales (2.41) suggest expensive pricing. Growth concerns include Revenue Growth at -35.00%, which may limit upside. Profitability pressure is visible in Return on Equity at -199.10%, Operating Margin at -3249.00%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -199.10% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -35.00% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
BNBX Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
BNBX's Price-to-Sales ratio of 2.41x sits near its historical average of 2.23x (86th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 0% below its historical high of 2.41x set in Mar 2026, and 19% above its historical low of 2.03x in Mar 2026.
WallStSmart Analysis Synopsis
Data-driven financial summary for Applied DNA Sciences, Inc. (BNBX) · FINANCIAL SERVICES › ASSET MANAGEMENT
The Big Picture
Applied DNA Sciences, Inc. operates as a stable business with moderate growth and solid fundamentals. Revenue reached 2M with 35% decline year-over-year.
Key Findings
Spending 22% of revenue (409,764) on R&D, reinforcing its commitment to innovation and future growth.
Revenue contracted 35% YoY. Worth determining whether this is cyclical or structural.
Free cash flow is -6M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Sector dynamics: monitor ASSET MANAGEMENT industry trends, competitive moves, and regulatory changes that could impact Applied DNA Sciences, Inc..
Bottom Line
Applied DNA Sciences, Inc. offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Applied DNA Sciences, Inc.(BNBX)
NASDAQ
FINANCIAL SERVICES
ASSET MANAGEMENT
USA
Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. The company is headquartered in Stony Brook, New York.